Related Experiment Video
Updated: Mar 14, 2026

Author Spotlight: Advancing Pathogen Detection and Disease Assessment in Real-Time Using M-ROSE
Published on: March 1, 2024
Rising burden of severe pediatric coccidioidomycosis: a 25-year single-center study
Sanchi Malhotra1, Kristina Adachi1, Ishminder Kaur1
1Department of Pediatrics, Division of Infectious Diseases, David Geffen School of Medicine, University of California Los Angeles, Los Angeles CA, United States.
Pediatric coccidioidomycosis cases are rising in California, with disseminated disease leading to longer hospital stays and complex treatments. Early recognition and multidisciplinary care are crucial for managing this serious fungal infection in children.
Area of Science:
- Infectious Diseases
- Pediatric Mycology
- Epidemiology
Background:
- California has seen a significant increase in pediatric coccidioidomycosis incidence.
- Disseminated coccidioidomycosis, though rare, causes severe illness in children.
- The expanding endemic area necessitates sharing clinical experiences.
Purpose of the Study:
- To analyze the clinical characteristics and outcomes of pediatric coccidioidomycosis at a regional referral center.
- To describe trends in primary and disseminated coccidioidomycosis over a 25-year period.
- To inform clinical management and highlight the need for specialized care.
Main Methods:
- Retrospective observational study of pediatric patients (0-17 years) diagnosed with coccidioidomycosis.
- Data collected from January 1, 2000, to June 30, 2025, at UCLA.
- Analysis of patient demographics, disease type, treatment, and outcomes.
Main Results:
- A significant increase in pediatric coccidioidomycosis cases was observed.
- Disseminated coccidioidomycosis cases rose sharply, particularly between 2023-2025.
- Patients with disseminated disease experienced longer hospitalizations, treatment durations, and higher rates of antifungal modification and surgical intervention.
Conclusions:
- Pediatric coccidioidomycosis presents increasing clinical severity and resource demands in endemic regions.
- Heightened clinical vigilance and early recognition of dissemination are essential.
- Multidisciplinary collaboration and evaluation of optimal treatment strategies are needed for pediatric cases.
Related Concept Videos
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Fungal Phylum Microsporidia
Cystic Fibrosis: Management
Sinus disease and chronic...
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...

